The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current revenue (TTM ) is NZ$55.62 Billion. an increase over the revenue in the year 2023 that were of NZ$44.57 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | NZ$59.26 B | 32.95% |
2023 | NZ$44.57 B | 7.52% |
2022 | NZ$41.46 B | 9.01% |
2021 | NZ$38.03 B | 7.94% |
2020 | NZ$35.23 B | 1.58% |
2019 | NZ$34.68 B | -2.02% |
2018 | NZ$35.40 B | 10.04% |
2017 | NZ$32.17 B | -3.07% |
2016 | NZ$33.19 B | 4.87% |
2015 | NZ$31.65 B | 23.6% |
2014 | NZ$25.60 B | 12.67% |
2013 | NZ$22.72 B | 8.29% |
2012 | NZ$20.98 B | 5.12% |
2011 | NZ$19.96 B | 2.32% |
2010 | NZ$19.51 B | -3.21% |
2009 | NZ$20.15 B | -22.02% |
2008 | NZ$25.85 B | 34.07% |
2007 | NZ$19.28 B | -4.79% |
2006 | NZ$20.25 B | 11.37% |
2005 | NZ$18.18 B | 23% |
2004 | NZ$14.78 B | 15.03% |
2003 | NZ$12.85 B | 23.59% |
2002 | NZ$10.40 B | 9.11% |
2001 | NZ$9.53 B | 21.01% |
2000 | NZ$7.87 B | 28.47% |
1999 | NZ$6.13 B | 22.29% |
1998 | NZ$5.01 B | 24.04% |
1997 | NZ$4.04 B | 29.92% |
1996 | NZ$3.11 B |